Welcome to our dedicated page for ARVL news (Ticker: ARVL), a resource for investors and traders seeking the latest updates and insights on ARVL stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ARVL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ARVL's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Arrival (Nasdaq: ARVL) has announced a 1-for-50 reverse stock split effective at 12:01 a.m. (ET) on April 14, 2023. This move aims to meet the minimum $1.00 bid requirement for maintaining its listing on Nasdaq. The extraordinary general meeting of shareholders held on April 6, 2023, approved this consolidation alongside a reduction in the company's authorized share capital to U.S.$540,000, resulting in approximately 15,262,180 Ordinary Shares outstanding, down from about 763 million. The reverse split will not affect shareholder percentage ownership or market capitalization and will be reflected in accounts automatically for shareholders. The company’s warrants and convertible notes will also undergo proportionate adjustments following the split.